NCT07352761Completed
Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy
Comparing Different Techniques of Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Brief summary (registry, in English)
The current study is a multiple-arm, single blinded, and controlled randomized trial. It will be conducted in two gynecological endoscopy centers: • ElShatby University Hospital, a tertiary level hospital in Alexandria, Egypt. • Al-Madina Women Hospital, A specialized hospital of Obstetrics and Gynecology, Alexandria, Egypt. Patient selection: women with uterine leiomyomata and planning for laparoscopic myomectomy will be assessed for eligibility then will be enrolled in the trial according to the following inclusion and exclusion criteria, after providing a written informed consent of participation. Outcome variables of the study: The primary outcome is intraoperative blood loss and the change in postoperative hemoglobin. The secondary outcomes of this study are the operative time of performing uterine arteries occlusion and the postoperative ovarian reserve.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 21 Dec 2025
- Start date
- 1 May 2025
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- Alexandria University
- NCT number
- NCT07352761
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 May 2025 to the primary completion date, 31 Jan 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- women with history of prior ovarian surgery,
- women with history of hormonal treatment for the last 3 months before surgery,
- Submucous fibroids who will undergo hysteroscopic myomectomy beside the laparoscopic surgery.
Other illness
- history of midline abdominal incisions,
- suspected endometrial malignancy or suspected leiomyosarcoma features on ultrasound and/or MRI.
Other
- contraindication to pneumoperitoneum and laparoscopy,
- patients with BMI \> 30 kg/m2,
- women who are not good candidate for myomectomy and who would benefit more from hysterectomy such as, women with multiple ≥ 4 leiomyomata, associated adenomyosis, recurrent fibroids after myomectomy.
Who the study is looking for
- women with uterine fibroids and complaining of either abnormal uterine bleeding, infertility, urinary or rectosigmoid pressure manifestations.
- Fibroid size from 3 - 10 cm in diameter and with
- a maximum number of 3 fibroids.
Sex: Female · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| • Al-Madina Women Hospital, A specialized hospital of Obstetrics and Gynecology, Alexandria, Egypt. Coordinator of this site? Confirm its status | Alexandria | Egypt | Unknown status |
| Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria Univeristy Coordinator of this site? Confirm its status | Alexandria | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.